LUNG CANCER

LUNG CANCER

Displaying 10 out of 15 results

  1. New Content Item

    More aggressive, spreads quickly: Why small cell lung cancers are hard to beat

    A new first-line treatment option has been approved for people battling extensive-stage small cell lung cancer, an aggressive disease strongly ...
  2. FILE PHOTO: Logo of Swiss drugmaker Roche is seen at its headquarters in Basel

    Roche wins FDA approval for immunotherapy cocktail against lung cancer

    Roche's Tecentriq immunotherapy mixed with chemotherapy won U.S. approval as an initial treatment for a form of lung cancer as the Swiss drugmaker ...
  3. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the

    AstraZeneca's Imfinzi gets speedy FDA review for small cell lung cancer

    British drugmaker AstraZeneca Plc said on Friday its cancer drug Imfinzi has been granted a speedy review by the U.S. Food and Drug Administration ...
  4. FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the

    AstraZeneca's combo drug for lung cancer succeeds in late-stage trial

    AstraZeneca Plc said on Monday a combination of its cancer drug, Imfinzi, along with chemotherapy helped curb progression of lung cancer in a ...
  5. FILE PHOTO: A man exercises on steps near the Lincoln Memorial in Washington

    Current and ex-smokers may lower lung cancer risk with exercise: Study

    Men who are current or former smokers may be less likely to develop or die from lung cancer when they're more physically fit, a recent study suggests.
  6. FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse

    Bristol-Myers immunotherapy combo outperforms chemo in lung cancer survival: study

    About 40per cent of patients who received a combination of Bristol-Myers Squibb Co's immuno-oncology drugs Opdivo and Yervoy as an initial ...